Tenaya Therapeutics (TNYA) Current Assets (2020 - 2026)

Tenaya Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $96.6 million for Q1 2026.

• On a quarterly basis, Current Assets rose 2.2% year-over-year to $96.6 million in Q1 2026; TTM through Mar 2026 was $96.6 million, a 2.2% increase from a year earlier, with the FY2025 full-year figure at $105.6 million, up 56.71% from the prior year.
• Current Assets fell to $96.6 million in Q1 2026 per TNYA's latest filing, from $105.6 million in the prior quarter.
• Across five years, Current Assets topped out at $213.8 million in Q1 2022 and bottomed at $61.2 million in Q3 2025.
• The 5-year median for Current Assets is $111.6 million (2023), against an average of $123.7 million.
• Biggest YoY gain for Current Assets was 64.01% in 2022; the steepest drop was 44.85% in 2022.
• Year by year, Current Assets stood at $193.8 million in 2022, then plunged by 42.41% to $111.6 million in 2023, then slumped by 39.62% to $67.4 million in 2024, then jumped by 56.71% to $105.6 million in 2025, then dropped by 8.55% to $96.6 million in 2026.
• Per Business Quant, the three latest TNYA Current Assets figures stand at $96.6 million (Q1 2026), $105.6 million (Q4 2025), and $61.2 million (Q3 2025).